SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-19-265555
Filing Date
2019-10-10
Accepted
2019-10-10 08:15:59
Documents
5
Period of Report
2019-10-10

Document Format Files

Seq Description Document Type Size
1 6-K d815926d6k.htm 6-K 13623
2 EX-99.1 d815926dex991.htm EX-99.1 22018
3 EX-99.2 d815926dex992.htm EX-99.2 74118
4 GRAPHIC g815926g1010100541960.jpg GRAPHIC 2327
5 GRAPHIC g815926g1010100542116.jpg GRAPHIC 2225
  Complete submission text file 0001193125-19-265555.txt   117373
Mailing Address 275 GROVE STREET SUITE 3-107 NEWTON MA 02446
Business Address 275 GROVE STREET SUITE 3-107 NEWTON MA 02446 617-600-6888
Stealth BioTherapeutics Corp (Filer) CIK: 0001696396 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38810 | Film No.: 191145346
SIC: 2834 Pharmaceutical Preparations